Neuroactive drugs in growth disorders

Acta Paediatr Scand Suppl. 1990:367:33-7. doi: 10.1111/j.1651-2227.1990.tb11629.x.

Authors

E Ghigo¹, E Mazza, J Bellone, E Arvat, E Imperiale, M Procopio, F Camanni

Affiliation

¹ Department of Clinical Physiopathology, University of Turin, Italy.

PMID: 2220385
DOI: 10.1111/j.1651-2227.1990.tb11629.x

No abstract available

Publication types

Review

MeSH terms

Bromocriptine / administration & dosage
Bromocriptine / therapeutic use
Central Nervous System / drug effects*
Child
Clonidine / administration & dosage
Clonidine / therapeutic use
False Negative Reactions
Growth Disorders / diagnosis
Growth Disorders / drug therapy*
Growth Hormone / metabolism
Growth Hormone / physiology
Growth Hormone-Releasing Hormone / administration & dosage
Growth Hormone-Releasing Hormone / pharmacology*
Humans
Levodopa / administration & dosage
Levodopa / therapeutic use
Pyridostigmine Bromide / administration & dosage
Pyridostigmine Bromide / pharmacology

Substances

Bromocriptine
Levodopa
Growth Hormone
Growth Hormone-Releasing Hormone
Pyridostigmine Bromide
Clonidine